1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. United States >
  5. Texas >
  6. TXE Capital Acquires Envirodyne Laboratories

M&A Deal Summary

TXE Capital Acquires Envirodyne Laboratories

On December 31, 2021, private equity firm TXE Capital acquired life science company Envirodyne Laboratories

Acquisition Highlights
  • This is TXE Capital’s 1st transaction in the Life Science sector.
  • This is TXE Capital’s 1st transaction in the United States.
  • This is TXE Capital’s 1st transaction in Texas.

M&A Deal Summary
Date 2021-12-31
Target Envirodyne Laboratories
Sector Life Science
Buyer(s) TXE Capital
Deal Type Buyout (LBO, MBO, MBI)
Advisor(s) Generational Group (Financial)

Target

Envirodyne Laboratories

Houston, Texas, United States
Envirodyne Laboratories is a full-service NELAP accredited environmental analytical testing laboratory. Envirodyne Laboratories services include methodologies for Inductively Coupled Plasma (ICP), ICP-MS (Metals), Gas Chromatography/Mass Spectrometer (GC/MS - Organics), Ion Chromatograph (IC), Microbiology, Wet Chemistry, and more. Envirodyne Laboratories was founded in 1991 and is based in Houston, Texas.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

TXE Capital

Investor

Category Private Equity Firm
Founded 2013
Size Small
Type Sector Focused
DESCRIPTION

TXE Capital is a private investment firm focused on the buying lower middle-market companies in the laboratory, testing, and inspection sectors. TXE Capital was established in 2013 and is headquartered in Houston, Texas.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal